Anavex Life Sciences Corp (AVXL)

[Doc328]

So the question then becomes, what else is going on? RETT will not longer float the boat imho...what else will move the stock? Core strength and undervaluation? It has been an ugly 60 miles of highway the last 7 months. Anybody got any ideas (not saying this summary is correct btw) on the Big Picture?

AD has LPLV May 2022 so I expect results September 2022 (would not be surprised if October, would be surprised if November) -- this will be huge

We will get more data from Avatar hopefully by May or June. If the 7 week response between A273 (meaning old endpoint, endpoint of US Rett and endpoint of trofinetide) and placebo is clearly significant and if 7 week response is at least as good as 4 week response (showing responses don't diminsh over time) --- this could be big (not huge but big).

Other stuff, 371 update, PDD OLE, won't move the needle much but could add a few bucks for a few days.

By Missling's timeline Excellence will report by end of June implying the study is now enrolled. Right..... Does TLD mean topline data or the late doctor? I expect 1H2023, maybe even Feb'ish.